{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:06:22Z","timestamp":1789589182051,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,31]],"date-time":"2027-08-31T00:00:00Z","timestamp":1819670400000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.labinv.2026.106154","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:10:50Z","timestamp":1784329850000},"page":"106154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Spatial Transcriptomic Profiling of Cribriform, Intraductal, Atypical Intraductal Proliferation, and Ductal Adenocarcinoma of the Prostate"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0768-4764","authenticated-orcid":false,"given":"Ting","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Nawrocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda T.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-0068","authenticated-orcid":false,"given":"Chin-Lee","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.labinv.2026.106154_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.urolonc.2024.01.037","article-title":"Ductal, intraductal, and cribriform carcinoma of the prostate: molecular characteristics and clinical management","volume":"42","author":"Shi","year":"2024","journal-title":"Urol Oncol"},{"issue":"Supp 1","key":"10.1016\/j.labinv.2026.106154_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/modpathol.2017.138","article-title":"High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate","volume":"31","author":"Zhou","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106154_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.eururo.2020.08.004","article-title":"The 2019 International Society of Urological Pathology consensus conference on prostate cancer grading","volume":"79","author":"van Leenders","year":"2021","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.labinv.2026.106154_bib4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/his.70046","article-title":"The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate","volume":"88","author":"Shah","year":"2026","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/path.5283","article-title":"Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations","volume":"249","author":"Khani","year":"2019","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.labinv.2026.106154_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00428-013-1385-5","article-title":"Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens","volume":"462","author":"Seipel","year":"2013","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.labinv.2026.106154_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PAS.0000000000002376","article-title":"Atypical intraductal proliferation in prostate needle core biopsy: validation as a marker of unsampled adverse pathology in a clinicopathologic series of 142 new patients","volume":"49","author":"Bhattarai","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12885-017-3976-z","article-title":"Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations","volume":"18","author":"Bottcher","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.labinv.2026.106154_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eururo.2017.04.034","article-title":"A prostate cancer \"nimbosus\": genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies","volume":"72","author":"Chua","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.labinv.2026.106154_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/modpathol.2008.236","article-title":"TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas","volume":"22","author":"Lotan","year":"2009","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.labinv.2026.106154_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.euf.2017.12.003","article-title":"Integrative genomic analysis of coincident cancer foci implicates CTNNB1 and PTEN alterations in ductal prostate cancer","volume":"5","author":"Gillard","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"10","key":"10.1016\/j.labinv.2026.106154_bib13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/modpathol.2009.103","article-title":"Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate","volume":"22","author":"Sanati","year":"2009","journal-title":"Mod Pathol"},{"issue":"7871","key":"10.1016\/j.labinv.2026.106154_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.labinv.2026.106154_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","article-title":"ISUP consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.labinv.2026.106154_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.labinv.2026.106154_bib18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106154_bib19","article-title":"Thirteen years of clusterProfiler","volume":"5","author":"Yu","year":"2024","journal-title":"Innovation (Camb)"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eururo.2023.03.014","article-title":"Impact of epithelial histological types, subtypes, and growth patterns on oncological outcomes for patients with nonmetastatic prostate cancer treated with curative intent: a systematic review","volume":"84","author":"Marra","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.labinv.2026.106154_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anndiagpath.2019.02.007","article-title":"Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type","volume":"39","author":"Au","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"10.1016\/j.labinv.2026.106154_bib22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/pros.22811","article-title":"Notch signaling in prostate cancer: a moving target","volume":"74","author":"Carvalho","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.labinv.2026.106154_bib23","article-title":"Notch as a driver of lineage plasticity and therapeutic target in enzalutamide-resistant prostate cancer","author":"Jiang","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib24","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/s41467-022-33780-1","article-title":"Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease","volume":"13","author":"Wong","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.labinv.2026.106154_bib25","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.3390\/ijms25094624","article-title":"Homologous recombination repair deficiency in metastatic prostate cancer: new therapeutic opportunities","volume":"25","author":"Piombino","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.labinv.2026.106154_bib26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2016.11.033","article-title":"Germline mutations in ATM and BRCA1\/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death","volume":"71","author":"Na","year":"2017","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.labinv.2026.106154_bib27","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41379-022-01093-9","article-title":"Enrichment of \"Cribriform\" morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer","volume":"35","author":"Shah","year":"2022","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.labinv.2026.106154_bib28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/jpm11070612","article-title":"Biomarkers for homologous recombination deficiency in cancer","volume":"11","author":"Wagener-Ryczek","year":"2021","journal-title":"J Pers Med"},{"issue":"216","key":"10.1016\/j.labinv.2026.106154_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2162004re2","article-title":"G proteins in cancer: the prostate cancer paradigm","volume":"2004","author":"Daaka","year":"2004","journal-title":"Sci STKE"},{"issue":"3","key":"10.1016\/j.labinv.2026.106154_bib30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0022-5347(05)65345-1","article-title":"Guanosine phosphate binding protein coupled receptors in prostate cancer: a review","volume":"167","author":"Raj","year":"2002","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.labinv.2026.106154_bib31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1158\/1541-7786.MCR-21-0927","article-title":"Exploiting dependence of castration-resistant prostate cancer on the arginine vasopressin signaling axis by repurposing vaptans","volume":"20","author":"Heidman","year":"2022","journal-title":"Mol Cancer Res"},{"issue":"11","key":"10.1016\/j.labinv.2026.106154_bib32","doi-asserted-by":"crossref","first-page":"12869","DOI":"10.18632\/oncotarget.7331","article-title":"SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.labinv.2026.106154_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101925","article-title":"Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer","volume":"44","author":"Wei","year":"2024","journal-title":"Transl Oncol"},{"key":"10.1016\/j.labinv.2026.106154_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-386503-8.00005-3","article-title":"A roundabout way to cancer","volume":"114","author":"Ballard","year":"2012","journal-title":"Adv Cancer Res"},{"issue":"11","key":"10.1016\/j.labinv.2026.106154_bib35","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.3390\/ijms26115265","article-title":"SLIT\/ROBO pathway and prostate cancer: gene and protein expression and their prognostic values","volume":"26","author":"Santos","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.labinv.2026.106154_bib36","first-page":"733","article-title":"[Clinical significance of SLIT2\/ROBO1 expression in prostate cancer]","volume":"54","author":"He","year":"2025","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"37","key":"10.1016\/j.labinv.2026.106154_bib37","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.1073\/pnas.0402069101","article-title":"NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival","volume":"101","author":"Zerbini","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"43","key":"10.1016\/j.labinv.2026.106154_bib38","doi-asserted-by":"crossref","first-page":"74506","DOI":"10.18632\/oncotarget.20171","article-title":"CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK\/Akt\/HIF-1alpha-induced twist expression","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.labinv.2026.106154_bib39","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/biom12081048","article-title":"Androgen-induced MIG6 regulates phosphorylation of retinoblastoma protein and AKT to counteract non-genomic AR signaling in prostate cancer cells","volume":"12","author":"Schomann","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.labinv.2026.106154_bib40","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.3390\/cancers12123862","article-title":"TMEFF2: a transmembrane proteoglycan with multifaceted actions in cancer and disease","volume":"12","author":"Masood","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.labinv.2026.106154_bib41","doi-asserted-by":"crossref","first-page":"16091","DOI":"10.1074\/jbc.M110.193805","article-title":"The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.labinv.2026.106154_bib42","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/s41388-019-0732-7","article-title":"Protein kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy","volume":"38","author":"Venkadakrishnan","year":"2019","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.labinv.2026.106154_bib43","doi-asserted-by":"crossref","first-page":"21501","DOI":"10.18632\/oncotarget.15308","article-title":"NRIP\/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib44","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-022-30257-z","article-title":"MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.labinv.2026.106154_bib45","article-title":"Role of RPL39 in metaplastic breast cancer","volume":"109","author":"Dave","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.labinv.2026.106154_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jcmm.17663","article-title":"Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K\/Akt\/mTOR signalling pathway","volume":"27","author":"Yi","year":"2023","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.labinv.2026.106154_bib47","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/biof.2083","article-title":"Identification and validation of the TRHDE-AS1\/hsa-miR-449a\/ADAMTS5 axis as a novel prognostic biomarker in prostate cancer","volume":"50","author":"Lian","year":"2024","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/acsptsci.9b00093","article-title":"The emerging role of adhesion GPCRs in cancer","volume":"3","author":"Gad","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/joim.12690","article-title":"Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis","volume":"283","author":"Heldin","year":"2018","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.labinv.2026.106154_bib50","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers7030860","article-title":"Targeting RTK signaling pathways in cancer","volume":"7","author":"Regad","year":"2015","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.labinv.2026.106154_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Target Ther"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372600084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372600084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:41:26Z","timestamp":1789587686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372600084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S002368372600084X"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106154","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Spatial Transcriptomic Profiling of Cribriform, Intraductal, Atypical Intraductal Proliferation, and Ductal Adenocarcinoma of the Prostate","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106154"}}